DOI: https://doi.org/10.22141/2307-1257.8.1.2019.157798

Thyroid dysfunction and kidney diseases

О.О. Melnik

Abstract


Thyroid hormones provide normal functioning of the kidneys, which in turn are not only an organ for the metabolism and excretion of thyroid hormones but also serve as targets for the action of certain thyroid hormones. Hypothyroidism and hyperthyroidism are associated with clinically significant changes in the activity of the kidneys. Hypothyroidism is accompanied by a decrease in glomerular filtration rate (GFR), hyponatremia and a change in the ability to excrete water from the body through the kidney. Elevated levels of thyroid hormones lead to an increase in GFR and renal blood flow. Renal failure affects thyroid function. Chronic kidney disease is accompanied by noticeable effects on the hypothalamus-pituitary-thyroid axis. There is a link between thyroid cancer and kidney tumors. Recent studies show that thyroid hormones, especially T3, can be considered as a marker of survival in patients with kidney disease.

Keywords


thyroid dysfunction; hypothyroidism; hyperthyroidism; chronic kidney disease; kidney failure

References


Feinstein EI, Kaptein EM, Nicoloff JT, Massry SG. Thyroid function in patients with nephrotic syndrome and normal renal function. Am J Nephrol. 1982;2(2):70-6. doi: 10.1159/000166587.

Kaptein EM. Thyroid function in renal failure. Contrib Nephrol. 1986;50:64-72.

Fonseca TL, Correa-Medina M, Campos MP, et al. Coordination of hypothalamic and pituitary T3 production regulates TSH expression. J Clin Invest. 2013 Apr;123(4):1492-500. doi: 10.1172/JCI61231.

Gereben B, Zavacki AM, Ribich S, et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev. 2008 Dec;29(7):898-938. doi: 10.1210/er.2008-0019.

Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002 Feb;23(1):38-89. doi: 10.1210/edrv.23.1.0455.

Braunlich H. Thyroid hormones influencing renal electrolyte excretion in saline loaded rats of different ages. Physiol Bohemoslov. 1984;33(4):303-8.

Gattineni J, Sas D, Dagan A, Dwarakanath V, Baum MG. Effect of thyroid hormone on the postnatal renal expression of NHE8. Am J Physiol Renal Physiol. 2008 Jan;294(1):F198-204. doi: 10.1152/aiprenal.00332.2007.

Katyare SS, Modi HR, Patel SP, Patel MA. Thyroid hormone-induced alterations in membrane structure-function relationships: studies on kinetic properties of rat kidney microsomal Na(C),K (C)-ATPase and lipid/phospholipid profiles. J Membr Biol. 2007 Oct;219(1-3):71-81. doi: 10.1007/s00232-007-9063-7.

Capasso G, De Tommaso G, Pica A, et al. Effects of thyroid hormones on heart and kidney functions. Miner Electrolyte Metab. 1999 Jan-Apr;25(1-2):56-64. doi: 10.1159/000057421.

Iglesias P, Bajo MA, Selgas R, Díez JJ. Thyroid dysfunction and kidney disease: An update. Rev Endocr Metab Disord. 2017 Mar;18(1):131-144. doi: 10.1007/s11154-016-9395-7.

Crowley WF, Jr, Ridgway EC, Bough EW, et al. Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med. 1977 Jan 6;296(1):1-6. doi: 10.1056/NEJM197701062960101.

Diekman MJ, Harms MP, Endert E, Wieling W, Wiersinga WM. Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients. Eur J Endocrinol. 2001 Apr;144(4):339-46.

Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. Minerva Endocrinol. 2004 Sep;29(3):139-50. doi: 10.1056/NEJM200102153440707.

Schmid C, Brandle M, Zwimpfer C, Zapf J, Wiesli P. Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor. Clin Chem. 2004 Jan;50(1):228-31. doi: 10.1373/clinchem.2003.021022.

Bradley SE, Coelho JB, Sealey JE, Edwards KD, Stephan F. Changes in glomerulotubular dimensions, single nephron glomerular filtration rates and the renin-angiotensin system in hypothyroid rats. Life Sci. 1982 Feb 15-22;30(7-8):633-9.

Montenegro J, Gonzalez O, Saracho R, Aguirre R, Martinez I. Changes in renal function in primary hypothyroidism. Am J Kidney Dis. 1996 Feb;27(2):195-8.

Vargas F, Moreno JM, Rodriguez-Gomez I, et al. Vascular and renal function in experimental thyroid disorders. Eur J Endocrinol. 2006 Feb;154(2):197-212. doi: 10.1530/eje.1.02.093.

van Hoek I, Daminet S. Interactions between thyroid and kidney function in pathological conditions of these organ systems: a review. Gen Comp Endocrinol. 2009 Feb 1;160(3):205-15. doi: 10.1016/j.ygcen.2008.12.008.

Zimmerman RS, Ryan J, Edwards BS, et al. Cardiorenal endocrine dynamics during volume expansion in hypothyroid dogs. Am J Physiol. 1988 Jul;255(1 Pt 2):R61-6. doi: 10.1152/ajpregu.1988.255.1.R61.

Garg LC, Tisher CC. Effects of thyroid hormone on Na-K-adenosine triphosphatase activity along the rat nephron. J Lab Clin Med. 1985 Nov;106(5):568-72.

Suher M, Koc E, Ata N, Ensari C. Relation of thyroid disfunction, thyroid autoantibodies, and renal function. Ren Fail. 2005;27(6):739-42.

Den Hollander JG, Wulkan RW, Mantel MJ, Berghout A. Correlation between severity of thyroid dysfunction and renal function. Clin Endocrinol (Oxf). 2005 Apr;62(4):423-7. doi: 10.1111/j.1365-2265.2005.02236.x.

Quesada A, Sainz J, Wangensteen R, Rodriguez-Gomez I, Vargas F, Osuna A. Nitric oxide synthase activity in hyperthyroid and hypothyroid rats. Eur J Endocrinol. 2002 Jul;147(1):117-22.

Singh G, Sharma AC, Thompson EB, Gulati A. Renal endothelin mechanism in altered thyroid states. Life Sci. 1994;54(24):1901-8.

Haro JM, Sabio JM, Vargas F. Renal beta-adrenoceptors in thyroxine-treated rats. J Endocrinol Invest. 1992 Sep;15(8):605-8.

Asmah BJ, Wan Nazaimoon WM, Norazmi K, Tan TT, Khalid BA. Plasma renin and aldosterone in thyroid diseases. Horm Metab Res. 1997 Nov;29(11):580-3. doi: 10.1055/s-2007-979105.

Kobori H, Ichihara A, Miyashita Y, Hayashi M, Saruta T. Mechanism of hyperthyroidism-induced renal hypertrophy in rats. J Endocrinol. 1998 Oct;159(1):9-14.

Manetti L, Pardini E, Genovesi M, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest. 2005 Apr;28(4):346-9.

Nakamura S, Ishiyama M, Kosaka J, Mutoh J, Umemura N, Harase C. Urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with Graves’ disease, subacute thyroiditis, and silent thyroiditis: A longitudinal study. Endocrinol Jpn. 1991 Jun;38(3):303-8.

Basu G. and Mohapatra A. Interaction between thyroid disordes and kidney disease. Indian J Endocrinol Metab. 2012 Mar;16(2):204-13. doi: 10.4103/2230-8210.93737.

Lim VS, Fang VS, Katz FI. Refetoff S. Thyroid dysfunction in chronic renal failure. A study of the pituitary thyroid axis and peripheral turnover kinetics of thyroxine and Triiodothyronine. J Clin Invest. 1977 Sep;60(3):522-34. doi: 10.1172/JCI108804.

Zoccali С, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P. Low triiodothyronine and survival in end-stage renal disease. Kidney Int. 2006 Aug;70(3):523-8. doi: 10.1038/sj.ki.5001566.

Hegedus L, Andersen JR, Poulsen LR, et al. Thyroid gland volume and serum concentrations of thyroid hormones in chronic renal failure. Nephron. 1985;40(2):171-4. doi: 10.1159/000183455.

Miki H, Oshimo K, Inoue H, et al. Thyroid carcinoma in patients with secondary hyperparathyroidism. J Surg Oncol. 1992 Mar;49(3):168-71.

Kaptein EM, Levitan D, Feinstein EI, Nicoloff JT, Massry SG. Alterations of thyroid hormone indices in acute renal failure and in acute critical illness with and without acute renal failure. Am J Nephrol. 1981;1(3-4):138-43. doi: 10.1159/000166531.

Bernet VJ. Reversible renal insufficiency attributable to thyroid hormone withdrawal in a patient with type 2 diabetes mellitus. Endocr Pract. 2004 Jul-Aug;10(4):339-44. doi: 10.4158/EP.10.4.339.

Kursat S, Alici T, Colak HB. A case of rhabdomyolysis induced acute renal failure secondary to statin-fibrate-derivative combination and occult hypothyroidism. Clin Nephrol. 2005 Nov;64(5):391-3.

Birewar S, Oppenheimer M, Zawada ET Jr. Hypothyroid acute renal failure. S D J Med. 2004 Mar;57(3):109-10.

Kar PM, Hirani A, Allen MJ. Acute renal failure in a hypothyroid patient with rhabdomyolysis. Clin Nephrol. 2003 Dec;60(6):428-9.

Sekine N, Yamamoto M, Michikawa M, et al. Rhabdomyolysis and acute renal failure in a patient with hypothyroidism. Intern Med. 1993 Mar;32(3):269-71.

Gurkan S, Dikman S, Saland MJ. A case of autoimmune thyroiditis and membranoproliferative glomerulonephritis. Pediatr Nephrol. 2009 Jan;24(1):193-7. doi:10.1007/s00467-007-0668-y.

Weetman AP, Pinching AJ, Pussel BA, Evans DJ, Sweny P, Rees AJ. Membranous glomerulonephritis and autoimmune thyroid disease. Clin Nephrol. 1981 Jan;15(1):50-1.

Ikeda K, Maruyama Y, Yokoyama M, et al. Association of Graves’ disease with Evans’ syndrome in a patient with IgA nephropathy. Intern Med. 2001 Oct;40(10):1004-10.

Dizdar O, Kahraman S, Gençtoy G, et al. Membranoproliferative glomerulonephritis associated with type 1 diabetes mellitus and Hashimoto’s thyroiditis. Nephrol Dial Transplant. 2004 Apr;19(4):988-9. doi: 10.1093/ndt/gfh059.

Kagiyama S, Tsuruta H, Tominaga M, Morishita K, Doi Y, Onoyama K. Minimal-change nephrotic syndrome and acute renal failure in a patient with aged onset insulin-dependent diabetes mellitus and autoimmune thyroiditis. Am J Nephrol. 1999;19(3):369-72. doi: 10.1159/000013479.

Brohee D, Delespesse G, Debisschop MJ, Bonnyns M. Circulating immune complexes in various thyroid diseases. Clin Exp Immunol. 1979 Jun;36(3):379-83.

Calder EA, Penhale WJ, Barnes EW, Irvine WJ. Evidence for circulating immune complexes in thyroid disease. Br Med J. 1974 Apr 6;2(5909):30-1.

Ebihara I, Hirayama K, Usui J, et al. Tubulointerstitial nephritis and uveitis syndrome associated with hyperthyroidism. Clin Exp Nephrol. 2006 Sep;10(3):216-21. doi: 10.1007/s10157-006-0423-x.

Hudde T, Heinz C, Neudorf U, Hoef S, Heiligenhaus A, Steuhl KP. Tubulointerstitial nephritis and uveitis (TINU syndrome) - comorbidity and complications in four patients. Klin Monbl Augenheilkd. 2002 Jul;219(7):528-32. doi: 10.1055/s-2002-33583.

Paydas S, Balal M, Karayaylali I, Seyrek N. Severe acute renal failure due to tubulointerstitial nephritis, pancreatitis, and hyperthyroidism in a patient during rifampicin therapy. Adv Ther. 2005 May-Jun;22(3):241-3.

Matto T. Hypothyroidism in infants with nephrotic syndrome. Pediatr Nephrol. 1994 Dec;8(6):657-9.

Silverberg DS, Ulan RA, Fawcett DM, Dossetor JB, Grace M, Bettcher K. Effects of chronic hemodialysis on thyroid function in chronic renal failure. Can Med Assoc J. 1973 Aug 18;109(4):282-6.

Rodrigues MC, Santos GM, da Silva CA, et al. Thyroid hormone transport is disturbed in erythrocytes from patients with chronic renal failure on hemodialysis. Ren Fail. 2004 Jul;26(4):461-6.

Junik R, Wlodarczyk Z, Masztalerz M, Odrowaz-Sypniewska G, Jendryczka E, Manitius J. Function, structure, and volume of thyroid gland following allogenic kidney transplantation. Transplant Proc. 2003 Sep;35(6):2224-6.

Rotondi M, Netti GS, Rosati A, et al. Pretransplant serum FT3 levels in kidney graft recipients are useful for identifying patients with higher risk for graft failure. Clin Endocrinol (Oxf). 2008 Feb;68(2):220-5. doi: 10.1111/j.1365-2265.2007.03022.x.

Acker CG, Flick R, Shapiro R, et al. Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). Am J Transplant. 2002 Jan;2(1):57-61.

Subramanian S, Goldstein DP, Parlea L, et al. Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid. 2007 Dec;17(12):1277-88. doi: 10.1089/thv.2007.0171.

Berthe E, Henry-Amar M, Michels JJ, et al. Risk of second primary cancer following differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2004 May;31(5):685-91. doi: 10.1007/s00259-003-1448-y.

Vezzadini C, Cremonini N, Sforza A, Presutti L, Chiarini V. Treated Wilm’s tumor in childhood as potential risk factor for second thyroid cancer. Panminerva Med. 2002 Sep;44(3):275-7.

Liou MJ, Lin JD, Chung MH, Liau CT, Hsueh C. Renal metastasis from papillary thyroid microcarcinoma. Acta Otolaryngol. 2005 Apr;125(4):438-42. doi: 10.1080/00016480410022822.

Kumar A, Nadig M, Patra V, Srivastava DN, Verma K, Bal CS. Adrenal and renal metastases from follicular thyroid cancer. Br J Radiol. 2005 Nov;78(935):1038-41. doi: 10.1259/bjr/24024066.

Oktay MH, Smolkin MB, Williams M, Cajigas A. Metastatic anaplastic carcinoma of the thyroid mimicking squamous cell carcinoma: report of a case of a challenging cytologic diagnosis. Acta Cytol. 2006 Mar-Apr;50(2):201-4. doi: 10.1159/000325932.

Insabato L, Di VD, De RG, Prezioso D, Corcione F, Terracciano LM. Renal metastasis from thyroid carcinoma 35 years after detection of the primary tumor. Tumori. 2003 Jan-Feb;89(1):99-101.

Eccles TG, Patel A, Verma A, Nicholson D, Lukes Y, Tuttle RM, Francis GL. Erythropoietin and the erythropoietin receptor are expressed by papillary thyroid carcinoma from children and adolescents. Expression of erythropoietin receptor might be a favorable prognostic indicator. Ann Clin Lab Sci. 2003 Fall;33(4):411-22.

McIntyre E, Bond P, Douglas F, Lennard T, Peaston R, Perros P. Multiple endocrine neoplasia type 2A: an unusual clinical presentation and association with renal dysplasia. Cancer Genet Cytogenet. 2003 Mar;141(2):157-9.

Calanas-Continente A, Espinosa M, Manzano-Garcıa G, Santamarı´a R, Lopez-Rubio F, Aljama P. Necrotizing glomerulonephritis and pulmonary hemorrhage associated with carbimazole therapy. Thyroid. 2005 Mar;15(3):286-8. doi: 10.1089/thv.2005.15.286.

Bendz H, Aurell M. Adverse effects of lithium treatment and safety routines. Lakartidningen. 2004 May 19;101(21-22):1902-6, 1908.

Kirk AD, Hale DA, Swanson SJ, Mannon RB. Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab. Am J Transplant. 2006 May;6(5 Pt 1):1084-5. doi: 10.1111/j.1600-6143.2006.01258.x.

Stein EM, Rivera C. Transient thyroiditis after treatment with lenalidomide in a patient with metastatic renal cell carcinoma. Thyroid. 2007 Jul;17(7):681-3. doi: 10.1089/thy.2006.0294.

Umemoto S, Izumi K, Kanno H. Two cases of hyperthyroidism induced by interferon-alpha therapy for renal cell carcinoma. Hinyokika Kiyo. 2007 Apr;53(4):225-9.

Rini BI, Tamaskar I, Shaheen P, et al. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst. 2007 Jan 3;99(1):81-3. doi: 10.1093/jnci/djk008.

Garfield DH, Hercbergs A, Davis PJ. Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst. 2007 Jun 20;99(12):975-6. doi: 10.1093/jnci/djm008.

Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev. 2001 Apr;22(2):240-54. doi:10.1210/edrv.22.2.0427.

Morales AI, Barata JD, Bruges M, et al. Acute renal toxic effect of amiodarone in rats. Pharmacol Toxicol. 2003 Jan;92(1):39-42. doi: 10.1034/j.1600-0773.2003.920107.x.

Paydas S, Balal M, Karayaylali I, Seyrek N. Severe acute renal failure due to tubulointerstitial nephritis, pancreatitis, and hyperthyroidism in a patient during rifampicin therapy. Adv Ther. 2005 May-Jun;22(3):241-3.

Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F. Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soc Nephrol. 2005 Sep;16(9):2789-95. doi: 10.1681/ASN.2005040356.






Copyright (c) 2019 KIDNEYS

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2019

 

   Seo анализ сайта